Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A study of human serum sickness.

T J Lawley, L Bielory, P Gascon

    The Journal of Investigative Dermatology
    |July 1, 1985
    PubMed
    Summary

    Horse antithymocyte globulin therapy for bone marrow failure frequently causes serum sickness. This condition, marked by immune complex formation, presents with fever, rash, and joint pain in most patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A sensitive and specific assay for the serological diagnosis of antilaminin 332 mucous membrane pemphigoid.

    The British journal of dermatology·2018
    Same author

    Clinical implications of mast cell involvement in allergic conjunctivitis.

    Allergy·2017
    Same author

    Complement activation.

    Immunology today·2014
    Same author

    Complementary and alternative therapy (CAM) in the treatment of allergic rhinitis.

    Current allergy and asthma reports·2014
    Same author

    Skin biopsies in the evaluation of atypical optic neuropathies.

    Ocular immunology and inflammation·2012
    Same author

    Impact of mometasone furoate nasal spray on individual ocular symptoms of allergic rhinitis: a meta-analysis.

    Allergy·2011

    Area of Science:

    • Immunology
    • Hematology
    • Dermatology

    Background:

    • Bone marrow failure necessitates treatments like horse antithymocyte globulin (h-ATG).
    • Serum sickness is a known adverse reaction to foreign proteins, including equine antitoxins.

    Purpose of the Study:

    • To investigate the incidence and clinical manifestations of serum sickness in patients receiving h-ATG for bone marrow failure.
    • To explore the immunological mechanisms underlying h-ATG-induced serum sickness.

    Main Methods:

    • Prospective study of 12 patients with bone marrow failure receiving daily intravenous h-ATG.
    • Clinical monitoring for serum sickness signs and symptoms (fever, rash, arthralgias, etc.).
    • Laboratory assessment including serum immune complexes, C3, and C4 levels; skin biopsy with direct immunofluorescence.

    Main Results:

    • Eleven of 12 patients (91.7%) developed serum sickness 8-13 days after h-ATG initiation.
    • Common symptoms included fever, malaise, rash, arthralgias, gastrointestinal issues, and lymphadenopathy.
    • Elevated circulating immune complexes and decreased C3/C4 levels were observed in most patients; skin biopsies showed immune deposits in some.

    Conclusions:

    • Horse antithymocyte globulin therapy is strongly associated with a high incidence of serum sickness in bone marrow failure patients.
    • Circulating immune complexes are central to the pathophysiology of this adverse reaction.
    • Early recognition of cutaneous signs like serpiginous erythema is important for diagnosis.

    Related Experiment Videos